Use "Flozins" Second-Line for Type 2 Diabetes

The American Diabetes Assn will endorse more drug combo choices for patients with type 2 diabetes.

Metformin plus lifestyle changes will remain first-line...but most type 2s will need 2 or more meds to reach glycemic goals.

SGLT2 inhibitors or "flozins" (Invokana, etc) will be a new second-line choice...along with sulfonylureas, glitazones (Actos, etc), gliptins (Januvia, etc), GLP-1 agonists (Victoza, etc), and insulin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote